Reformulated HIV treatment will save more children’s lives, says UN




Whatsapp News

York- U.S. Food and Drug Administration (FDA) has approved a anti-retroviral formulation that can be mixed with food, making easier for children living with HIV take their life-saving medicines.
This is contained in a joint issued Saturday by Programme HIV/AID (UNAIDS) and the Children’s Fund (UNICEF).
quoted the UNAIDS Director, Mr Michel Sidibe, as saying that treatment innovations such as the that replaces unpleasant and bad-tasting medicines were a real breakthrough.
Sidibe said the development would accelerate access treatment for children and keep them healthy.
According him, only 24 per cent of children living with HIV have access antiretroviral drugs.
The UNAIDS chief also said the treatment was heat stable and more palatable than medicines currently available, making particularly suitable for treating very young children.
“Produced by Indian generic medicines manufacturer, CIPLA, the oral pellets contain an anti-retroviral formulation of lopinavir and ritonavir that can be mixed into a ’s food,” he explained.

[pro_ad_display_adzone id=”70560″]
Mr Craig McClure, UNICEF’s Chief of HIV/AIDS section said the formula was a step in the right direction towards saving the lives of more children living with HIV.
“We expect the medication to greatly treatment access for more children and support UNICEF’s equity-focused programming aimed at reaching the most disadvantaged children throughout the world,” McClure said in the .

HIV infection progresses rapidly in children and, in highly-impacted countries, was a major contributor to morbidity and mortality.
Without treatment, in three children who become infected with HIV would die before his or her first and also half would die before their second .
Early initiation of antiretroviral treatment in children substantially reduced the risk of .
Reports say in spite of global efforts to accelerate access to HIV paediatric care and treatment, fewer than 800,000 of the 3.2 million children living with HIV had access to antiretroviral medicines in 2013. (PANA/NAN)